Versant Capital Management, Inc Atri Cure, Inc. Transaction History
Versant Capital Management, Inc
- $431 Million
- Q3 2024
A detailed history of Versant Capital Management, Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 46 shares of ATRC stock, worth $1,413. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46
Previous 86
46.51%
Holding current value
$1,413
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ATRC
# of Institutions
212Shares Held
49.7MCall Options Held
12KPut Options Held
7.2K-
Vanguard Group Inc Valley Forge, PA4.66MShares$143 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$142 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.97MShares$122 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.83MShares$87 Million1.47% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.79MShares$85.7 Million0.5% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.43B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...